Enhanced phagocytosis and cytotoxicity of co-activated FcRγ-BAI1/FcRγ-MERTK dual-CAR monocytes drive potent anti-solid tumor activity
Chimeric antigen receptor macrophages (CAR-M) display superior tumor infiltration compared with CAR-T cells for solid tumor therapy, yet limited antitumor potency and antigen heterogeneity hinder their application. Direct engineering of chimeric antigen receptor monocytes (CAR-Mo) offers a simplified, cost-effective manufacturing alternative. Here, we engineered THP-1-derived monocytic cells with chimeric receptors containing FcRγ fused to phagocytosis-related cytoplasmic domains, targeting nucleolin and HER2. We constructed single-target and dual-antigen CAR-Mo platforms and evaluated their antitumor activity in vitro and in vivo . THP-1 monocytes carrying FcRγ-BAI1 or FcRγ-MERTK receptors exhibited enhanced phagocytosis, and dual-CAR-Mo achieved broader and stronger tumoricidal effects by targeting two tumor antigens. This dual-antigen-targeted CAR-Mo strategy activates both phagocytic and cytotoxic signaling pathways and represents a promising approach for solid tumor treatment. Collectively, this dual-target CAR-Mo strategy demonstrates promising antitumor efficacy in the THP-1 cell model, providing a feasible prototype for future optimization of solid tumor immunotherapy.
Authors
- Zhaojun Duan (ORCID: https://orcid.org/0000-0001-6530-3158)
- Yunping Luo (ORCID: https://orcid.org/0000-0002-9151-9160)
- Lingyu Ma
- Qin Si
- Huifang Su
- Jiayu Jiang
- Hui Chen
- Zhen Li
- Chong Chen
- Xiaotian Chen
- Chen Zhang
- Wei Wang
- Chang Liu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences (CN)
Publication Details
- Journal
- iScience
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.isci.2026.118216
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chinese Academy of Medical Sciences
- Wuhan University
- Peking Union Medical College